Categories
Health

Company provides closing OK to manage Covid vaccine booster pictures to susceptible Individuals

The Centers for Disease Control and Prevention on Friday gave final approval to give Covid-19 booster vaccinations to recipients of Pfizer and Moderna vaccines, hours after a key panel unanimously voted to allow third doses for immunocompromised Americans advocate.

“At a time when the Delta variant is on the rise, an extra dose of vaccine for some people with compromised immune systems could help prevent serious and potentially life-threatening COVID-19 cases in this population,” said CDC Director Dr . Rochelle Walensky in a statement.

The CDC’s decision and recommendation by the Advisory Committee on Immunization Practices followed the approval of the booster vaccination for immunocompromised patients by the Food and Drug Administration late Thursday. With the OK from both authorities, the booster doses could be given immediately.

“For the past almost a year and a half, I have cared for many patients with life-threatening and fatal diseases, and even post-vaccination,” who are immunocompromised, Dr. Camille Nelson Kotton, a transplant and infectious disease specialist at Massachusetts General Hospital, told the panel to strongly support boosters for those with weak immune systems. “They just suffer from a lack of good vaccination protection, we know that the vaccine is less effective in this population.”

Close-up of the Moderna vaccine at the Park County Health Department’s COVID-19 Vaccination Clinic for Seniors 80 and older on January 28, 2021 in Livingston, Montana.

William Campbell | Getty Images

FDA approval approved third doses of Pfizer and Moderna vaccines for “solid organ transplant recipients or those diagnosed with conditions believed to have equivalent levels of immunodeficiency.”

“New data suggests that some people with moderately to severely compromised immune systems do not always build the same level of immunity as people who are not immunocompromised,” said Walensky. “While immunocompromised people make up about 3% of the US adult population, they are particularly vulnerable to COVID-19 because they are at greater risk of developing serious, longer-lasting illnesses.”

Authorities have not released a booster vaccination to anyone else fully vaccinated or to recipients of Johnson & Johnson’s vaccine, which is manufactured in the Janssen vaccines division.

“There is currently no data to support the use of an additional dose of mRNA COVID-19 vaccine following a Janssen Covid-19 primary vaccine in immunocompromised people. The FDA and CDC are actively working to provide guidance on this matter,” said Dr. Neela. from CDC Goswami wrote to ACIP in her presentation.

The CDC recommended a third dose for at-risk Americans 28 days or more after completing the first two rounds of shooting. Booster doses are also recommended for cancer patients and HIV patients after data showed that immune responses after the first two doses did not provide adequate protection against Covid-19 and its variants in these patients.

The additional recordings were recommended for Pfizer recipients aged 12 and over and for Moderna recipients aged 18 and over. The panel said it will revisit the recordings for younger Moderna recipients after the FDA clears the recordings for children.

Immunocompromised patients make up approximately 2.7% of the US adult population and 44% of breakthrough hospital-treated infections that make someone infected even after being fully vaccinated.

Studies suggest that a third dose of the vaccine might help people whose immune systems do not respond as well to a first or second dose. Five small studies cited by the CDC showed that 11% to 80% of people with compromised immune systems had no detectable antibodies to Covid after two shots.

Among immunocompromised patients who had no detectable antibody response, 33 to 50% developed an antibody response after receiving an additional dose, according to the CDC.

Patients at risk are also more likely to experience persistent Covid infections, the panel said. The data also suggests that they are likely to shed more viruses and potentially infect more people than those who are not immunocompromised.

Early data from small studies on the effects of booster doses in immunocompromised patients showed no serious side effects from a third vaccination with an mRNA vaccine and symptoms beyond those identified after the first two-dose dose.

Several countries, including Israel, the Dominican Republic, France, the UK and Germany, have either already started or are considering giving booster doses of Covid-19 vaccines.

Immunocompromised patients receiving a third dose should continue to wear a mask and social distancing, the panel said.

Survey data from hesitant immunocompromised patients show that, according to a panel presentation by Dr. Kathleen Dooling of the CDC still has many worried about the side effects of the vaccines and the speed at which the vaccines have been developed, as well as the general suspicion about the vaccines.

Around 10% of immunocompromised patients say they will “definitely not” receive a vaccine, another 9% say they are “unsure” or “probably not” and 44% say they will “definitely” get a vaccine. Those who hesitate are usually younger, belong to an ethnic or racial minority, or are female.

Categories
Health

Ohio Clinic Says It Will not Administer Alzheimer’s Drug to Sufferers

In a conspicuous concern about the approval of the controversial new Alzheimer’s drug Aduhelm, the Cleveland Clinic said Wednesday evening that it would not give it to patients.

The clinic, one of the largest and most respected medical centers in the country, said in a statement a panel of experts had “reviewed all available scientific evidence about this drug,” also called aducanumab.

“Based on the current data on safety and effectiveness, we have decided not to wear aducanumab at the moment,” the statement said.

A spokeswoman for the clinic said individual doctors there could prescribe Aduhelm to patients, but those patients would have to go elsewhere to get the drug, which is given as an intravenous infusion every month.

The stance of the major medical center is the latest fallout from the approval of the drug by the Food and Drug Administration on June 7, a decision that also fueled Congressional investigations.

Many Alzheimer’s experts and other scientists have said that it is unclear that the drug helps slow cognitive decline and that at best the evidence suggests only a slight slowdown while showing that Aduhelm causes brain swelling or hemorrhage could.

Recognition…Biogen, via Associated Press

The drug is also expensive. Biogen, the maker, has set its price at $ 56,000 per year.

In a recent survey of nearly 200 neurologists and primary care physicians, most said they disagreed with the FDA’s decision and did not plan to prescribe the drug to their patients.

Last week, Dr. Janet Woodcock, acting FDA commissioner, in response to growing criticism of an independent state investigation into the agency’s regulatory process, wrote, “To the extent that these concerns could undermine public confidence in the FDA’s decision, I believe” it is critically important that the disputed events are reviewed by an independent body. “

Two almost identical clinical trials with Aduhelm were stopped prematurely because an independent data monitoring committee concluded that the drug did not appear to be helping patients. A later analysis by Biogen found that participants who received the high dose of the drug in one study experienced a very slight slowdown in cognitive decline – 0.39 on an 18-point scale – that participants in the other study however, had not benefited from it at all.

About 40 percent of study participants developed cerebral hemorrhage or swelling, and while most of these cases were mild or manageable, about 6 percent of participants dropped out because of serious side effects from these conditions.

After reviewing the data late last year, an FDA advisory committee strongly recommended outside experts against approval, and three of its members resigned in protest last month when the agency defied the advice of the advisory committee. The American Geriatrics Society had also urged the agency not to approve the drug because it was “premature in the absence of sufficient evidence.”

In response to widespread criticism that Aduhelm was approved for anyone with Alzheimer’s, the FDA last week severely restricted the drug’s recommended use, saying that it should only be used for people with mild memory or thinking problems as it doesn’t have any Data on the use of Aduhelm gave later stages of Alzheimer’s disease.

Categories
Health

Dentists, veterinarians and med college students licensed to manage pictures in U.S.

A U.S. Army soldier with the 2nd Armored Brigade Combat Team, 1st Infantry Division immunizes Jacklina Mendez with the COVID-19 vaccine on March 9, 2021 on the north campus of Miami Dade College in North Miami, Florida.

Joe Raedle | Getty Images

The Biden government will allow a wider range of medical professionals, including dentists, veterinarians, paramedics and medical students, to administer Covid-19 shots to bring the nation closer to normal by midsummer.

The U.S. Department of Health is using its powers under the Public Preparedness and Emergency Preparedness Act to empower more healthcare professionals and qualified students to manage the admissions, the agency said in a statement Friday.

That means dentists, paramedics, midwives, opticians, paramedics, medical assistants, podiatrists, respiratory therapists and veterinarians can start giving Covid-19 vaccines nationwide, according to HHS.

It also empowers “medical students, nursing students and other health care students in the professions listed in the PREP Act with appropriate training and professional supervision to act as vaccines,” the statement said.

The move comes after President Joe Biden announced Thursday night that he would instruct all U.S. states, tribes, and territories to qualify all adults ages 18 and older for the coronavirus vaccines by May 1.

The president, during his first prime-time address to the nation on the one-year anniversary of the pandemic, said the goal was for Americans to gather in small, face-to-face groups to celebrate July Fourth.

“That doesn’t mean everyone gets a shot right away, but May 1st is the date that any adult can sign up to get the shot,” Biden’s Covid Tsar Jeff Zients said at a press conference on Friday. “We expect an adequate vaccine supply for all adults in this country by the end of May.”

The US currently delivers an average of 2.2 million vaccines per day per week. About 65% of Americans age 65 and over are now vaccinated, Zients said. Only more than a quarter of adults 18 and older have received at least one vaccine, according to the latest data from the Centers for Disease Control and Prevention.

“We are making progress, but there is still a lot to be done,” he said.

On Monday, the CDC released its first guidelines for people who are fully vaccinated. These state that they can now converse with other vaccinated individuals inside without masks or social distancing.

Categories
Health

U.S. to vary allocation to favor states that shortly administer photographs

The federal government is changing the way coronavirus vaccine doses are allocated, now based on how quickly states can administer shots and how large their elderly population is, Minister of Health and Human Services Alex Azar said Tuesday.

States have two weeks to prepare for the change, Azar told reporters during a news conference. This should give states enough time to report their data to the government and ensure that all vaccinations are documented “promptly,” he said.

States are currently not reporting vaccinations in a timely manner, Azar said, adding that vaccine doses “sit in hospital freezers”.

The announcement comes as the Centers for Disease Control and Prevention issues new guidelines that extend eligibility for coronavirus vaccines to anyone over 65, as well as those with comorbid conditions like diabetes and heart disease. States’ focus on vaccinating health workers and nursing homes has created a bottleneck that is slowing the pace of vaccination, a senior administrative official told CNBC.

“The states should not wait to complete the prioritization of phase 1a before moving on to broader categories of eligibility,” said Azar on Tuesday the new guidelines. “Think of it like getting on a plane. You may have a sequential order in which you board people. But you don’t wait for literally every person in a group to board before moving on to the next . ”

The Trump administration will also stop withholding millions of doses reserved for the second round of vaccinations with Pfizer’s and Moderna’s two-dose vaccines, the official said, adding it released doses that were held in reserve Sunday . President-elect Joe Biden’s transition team announced a similar plan on Friday.

Approximately 53 million Americans 65 and older and 110 million people 16 to 64 years old with comorbid conditions can now get the vaccine if each state adopts the CDC guidelines.

The vaccine doses were previously assigned based on the number of adults in each state. But US officials complain that the pace of vaccinations has been too slow as the supply of vaccine doses exceeds demand.

Arkansas and Georgia are the two worst performers, vaccinating 1,355 and 1,346 people per 100,000, respectively, according to CDC data. The Dakotas and West Virginia now fire more than 5,000 shots per 100,000 people, according to the agency.

As of Monday morning, more than 25.4 million doses had been distributed in the US, but just over 8.9 million shots had been administered according to CDC data. The number is a far cry from the federal government’s goal of vaccinating 20 million Americans by the end of 2020 and 50 million Americans by the end of this month.

State and local health officials have said they are strapped for cash. They blame insufficient funding and inconsistent communication from the federal government for the slow roll-out.

To speed up the pace of vaccinations, Dr. Stephen Hahn, Commissioner for the Azar and Food and Drug Administration, told states last week to begin vaccinating lower priority groups against Covid-19.

The CDC recommended immunizing health care workers and nursing homes first, but states are free to distribute the vaccine at their discretion. Hahn told reporters that states should give shots to groups that “make sense” such as the elderly, people with pre-existing conditions, police, fire departments and other key workers.

Azar admitted on Tuesday that the government’s guidelines are new, adding that vendors typically have a month to report their data instead of days. “This is a big change in the workflow for them. There will be kinks in the system for them in relation to this data,” he said.

Categories
Health

Operating low on oxygen, emergency employees in Los Angeles County are advised to manage the minimal vital.

California’s daily coronavirus case numbers remain about four times what it was during the state’s summer flood, and officials predict the aftermath of a December wave related to holiday gatherings will worsen over the winter.

After new infections – fueled by Thanksgiving trips and gatherings, then Christmas festivities – led to a surge the state hadn’t seen before, the trend in its new cases flattened somewhat in the early days of 2021.

But there are more than twice as many Covid-19 patients in California hospitals as there were a month ago, and many intensive care units in the state are overcrowded. It has also been found that at least six people in the state are infected with the new, more transmissible variant of the virus first identified in the UK.

The state is also facing a lack of oxygen for patients and has deployed the U.S. Army Corps of Engineers and the California Emergency Medical Services Authority to help with the delivery and refilling of oxygen tanks.

As a sign of how bad the shortage is, Marianne Gausche-Hill, the medical director of the Los Angeles County EMS agency, issued guidelines on Sunday for emergency responders to administer the “minimum amount of oxygen” required keep the patient’s oxygen saturation at a level or just over 90 percent. (Levels in their low 90s or below are an issue for people with Covid-19.)

In the brutal logic of the pandemic, more cases inevitably lead to more suffering and death. As of Monday evening, 4,258 people had died with Covid-19 in the past two weeks, compared to 3,043 in the two weeks prior.

Updated

Jan. 5, 2021, 6:31 p.m. ET

“This is a deadly disease, this is a deadly pandemic,” Governor Gavin Newsom told reporters on Monday. “It remains deadlier today than at any point in the history of the pandemic.”

Some progress has been made. For example, California’s daily average of 38,086 cases per day for the past week is an 11 percent decrease from the average for two weeks earlier. And although hospital stays in Covid-19 have increased 18 percent to 20,618 in the past two weeks, that means a slight flattening of the curve, according to Governor Newsom.

But the state’s last major Covid-19 surge in the summer only caused about 10,000 infections on the worst days. And in Los Angeles County, the recent crisis has made the healthcare system so thin that patients arriving at a hospital were recently ordered to wait in an outdoor tent.

Los Angeles Mayor Eric Garcetti said Sunday that the county’s recent spike infected a new person every six seconds and that many transmissions were in private settings.

“It’s a message for all of America: We may not all have the same density as LA, but what is happening in LA can and will come to many churches in America,” he said.

The state’s worst outbreak is centered in southern California and the San Joaquin Valley, where intensive care units are zero percent. Officials are now working to recruit additional nurses to handle the flood of patients. Governor Newsom said 90 patients were being held in “alternative care locations” outside of hospitals to ease the burden.

More vaccinations would help ease the burden on California, but Governor Newsom said vaccinations were only just increasing after some early challenges. So far, the state has only administered about 35 percent of the coronavirus vaccine doses received.

“That’s not good enough,” he said. “We recognize that.”

In the meantime, says Dr. Mark Ghaly, the secretary of state for health and human services, Californians should be extra careful when meeting with people outside of their household as the virus is so widespread.

“The same activities that you did a month ago today are much riskier today than from a Covid transmission perspective,” he said.